Article
Airway and peripheral urokinase plasminogen activator receptor is elevated in asthma, and identifies a severe, nonatopic subset of patients.
Allergy - 1 Mar 2017
Portelli M A, Moseley C, Stewart C E, Postma D S, Howarth P, Warner J A, Holloway J W, Koppelman G H, Brightling C, Sayers I
Abstract excerpt
RATIONALE: Genetic polymorphisms in the asthma susceptibility gene, urokinase plasminogen activator receptor (uPAR/PLAUR) have been associated with lung function decline and uPAR blood levels in asthma subjects. Preliminary studies have identified uPAR elevation in asthma; however, a definitive study regarding which clinical features of asthma uPAR may be driving is currently lacking. OBJECTIVES: We aimed to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
